Introduction: Opioids work to lessen pain intensity, but they do affect the overall
quality of life (QoL) because of their good points and side effects, and they include
sedation and constipation. New methods like skin patch opioids and mixed
medicines seek to manage pain well and lower harmful effects. Results: Studies,
both those that were published between January 2018 and May 2025 synthesized
evidence. The synthesis shows opioid therapy improves physical QoL domains
much since it reduces pain harshness and betters functional status in cancer
patients. Transdermal opioids, including fentanyl and buprenorphine, are
associated with greater patient satisfaction and fewer gastrointestinal side effects
compared to oral formulations. However, the psychological and social aspects of
QoL show less consistent improvement, with many patients continuing to report
emotional distress, sleep disturbances, and social withdrawal. Negative
consequences, especially constipation caused by opioids and the potential for
dependence, continue to be major obstacles to achieving optimal quality of life.
Conclusions: Opioid treatment is essential for managing cancer pain effectively and
can significantly improve the physical quality of life for patients experiencing
chronic cancer pain. Future pain management strategies should emphasize
individualized opioid regimens, proactive management of adverse effects, and
integration of supportive psychosocial interventions to optimize quality of life
outcomes for cancer patients.
Keywords: cancer pain, opioid therapy, quality of life, transdermal opioids, opioidinduced
constipation.
